Nano Cap New Millennium Growth Fund L P Purchases Shares of 825,000 Seer, Inc. $SEER

Nano Cap New Millennium Growth Fund L P purchased a new stake in Seer, Inc. (NASDAQ:SEER) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 825,000 shares of the company’s stock, valued at approximately $1,510,000. Seer makes up approximately 1.3% of Nano Cap New Millennium Growth Fund L P’s holdings, making the stock its 20th largest holding.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Palumbo Wealth Management LLC lifted its position in shares of Seer by 22.4% during the 3rd quarter. Palumbo Wealth Management LLC now owns 128,980 shares of the company’s stock worth $280,000 after buying an additional 23,604 shares during the last quarter. Susquehanna International Group LLP lifted its position in shares of Seer by 22.8% during the 3rd quarter. Susquehanna International Group LLP now owns 123,447 shares of the company’s stock worth $268,000 after buying an additional 22,918 shares during the last quarter. Jane Street Group LLC lifted its position in shares of Seer by 33.3% during the 1st quarter. Jane Street Group LLC now owns 254,174 shares of the company’s stock worth $430,000 after buying an additional 63,432 shares during the last quarter. Bridgeway Capital Management LLC lifted its position in shares of Seer by 15.5% during the 2nd quarter. Bridgeway Capital Management LLC now owns 837,443 shares of the company’s stock worth $1,792,000 after buying an additional 112,100 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Seer by 0.9% in the 3rd quarter. Vanguard Group Inc. now owns 2,221,404 shares of the company’s stock valued at $4,820,000 after purchasing an additional 18,760 shares during the period. 75.20% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SEER. Weiss Ratings reissued a “sell (d-)” rating on shares of Seer in a research report on Tuesday, April 21st. Canaccord Genuity Group initiated coverage on Seer in a research report on Monday, May 4th. They issued a “buy” rating and a $4.00 target price for the company. Finally, TD Cowen raised shares of Seer to a “strong-buy” rating in a research report on Monday, April 13th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $4.00.

Seer Trading Up 5.4%

Shares of NASDAQ SEER opened at $1.77 on Friday. The stock has a market cap of $99.86 million, a price-to-earnings ratio of -1.43 and a beta of 1.63. Seer, Inc. has a 52 week low of $1.65 and a 52 week high of $2.41. The company’s 50-day moving average price is $1.80 and its 200 day moving average price is $1.87.

Seer (NASDAQ:SEER) last released its earnings results on Wednesday, May 13th. The company reported ($0.30) earnings per share for the quarter, hitting the consensus estimate of ($0.30). The firm had revenue of $2.79 million for the quarter, compared to the consensus estimate of $3.60 million. Seer had a negative return on equity of 26.58% and a negative net margin of 464.78%.

Seer Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.